Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates

Julia Chocarro1,2,3, Alberto J Rico1,2,3, Goiaz Ariznabarreta1,2,3

  • 1CNS Gene Therapy Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.

PubMed
Summary

Neuromelanin accumulation in macaques triggered Parkinson's disease (PD) pathology, including alpha-synuclein aggregation and neuron loss. This finding suggests targeting neuromelanin could be a novel therapeutic strategy for PD.